window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Precision medicine

  • Clinical Development,Precision medicine,Rare Diseases,Real world evidence,Research & Development,Technology and platforms

    Nautilus and the Allen Institute partner to map tau proteoforms in Alzheimer’s disease research

    Nautilus Biotechnology has announced a new collaboration with the Allen [...]

    August 4, 2025
  • Precision medicine,Research & Development,Technology and platforms

    New England Biolabs launches low-bias small RNA library prep kit to improve RNA sequencing accuracy

    New England Biolabs (NEB) has introduced the NEBNext Low-bias Small [...]

    July 29, 2025
  • Clinical Development,Drug Development,Precision medicine,Research & Development,Technology and platforms

    AltPep data highlights potential of intranasal peptide for early-stage Alzheimer’s

    AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

    July 28, 2025
  • Drug Development,Global health,Precision medicine,Rare Diseases,Research & Development,Technology and platforms

    First Arab human pangenome reveals millions of novel variants using long-read sequencing

    Study powered by PacBio HiFi sequencing offers new insight into [...]

    July 28, 2025
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Movers & Shakers,Oncology,Precision medicine

    PhoreMost appoints Pfizer drug discovery veteran Dr Adam Gilbert to scientific advisory board

    Appointment strengthens expertise in targeted protein degradation as company advances [...]

    July 28, 2025
  • Clinical Trials,European biotech,Oncology,Partnerships & Funding,Precision medicine,Research & Development

    MaaT Pharma lands €37.5M EIB loan to boost microbiome cancer pipeline

    Tranche-based debt financing will support EMA review of Xervyteg and [...]

    July 28, 2025
  • Artificial Intelligence,Clinical Trials,Patient Centricity,Precision medicine,Technology and platforms

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    July 28, 2025
  • Clinical Trials,Global health,Oncology,Precision medicine,Rare Diseases,Regulatory Affairs,Research & Development

    CHMP backs Gilead’s twice-yearly lenacapavir for HIV prevention under accelerated EMA review

    Gilead Sciences has received a positive opinion from the Committee [...]

    July 25, 2025
  • Global health,Partnerships & Funding,Precision medicine,Rare Diseases,Research & Development,Technology and platforms

    PacBio brings isoform-level insights to 1000 Genomes Project with HiFi sequencing

    PacBio is contributing long-read transcriptomic data to the 1000 Genomes [...]

    July 25, 2025
  • Artificial Intelligence,Oncology,Precision medicine

    Biostate AI expands RNA-based precision medicine with new partnerships across China, India and the US

    Global collaborations boost dataset powering AI diagnostics for cancer, cardiovascular [...]

    July 24, 2025
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top